RANCHO SANTA MARGARITA, Calif., Feb. 21, 2018 -- Melissa, a leading provider of global contact data quality and identity verification solutions, today launched Melissa Informatics, fueled by its acquisition of semantic technology firm, IO Informatics (IOI). IOI’s software and services support global leaders in life sciences, biotechnology, pharmaceutical, and medical industries, reducing time and cost to benefit from clean, richly connected data. The firm helps realize value from complex, changing data by revealing deeper data relationships through machine learning and reasoning operations. Melissa Informatics, operating as a division of Melissa, integrates a global intelligence toolset to extend these capabilities in healthcare markets and beyond, buoyed by a worldwide enterprise sales and support infrastructure.
“Semantics is a transformative technology in the data quality realm, tapping into machine learning to automate, accelerate, and perfect the application of data. It’s a natural fit for Melissa and our comprehensive approach to solving complex data challenges for an enterprise client base worldwide,” said Daniel Kha Le, vice president, Melissa Informatics. “Traditional integrations are not inherently built for global interoperability, and we’re now able to extend integrations beyond this limitation. We can empower a faster and easier path to data merging and compatibility with all types of standards, harmonizing data to find patterns and relationships that were previously unrecognizable.”
Semantic technology is optimized for data management environments rich in variables, diversity, and complexity. Because semantic processes consider context clues to evaluate structured or unstructured data, a single request can efficiently query numerous disparate or siloed data sources – or inconsistent data in the same database – and deliver more meaningful results than traditional relational data methods.
In one industry example, a single medication may be referenced in hundreds of different ways, even in the same set of electronic health records. Context-based reasoning can connect and standardize these references to optimize data for analytics. Extracting significantly greater value from data held by pharma and healthcare leaders, this process eliminates the end-user’s need to conduct costly clinical trials for additional data acquisition.
“Melissa Informatics is removing risk inherent in high-value, high-complexity data integrations, connecting with existing data that is underused and hidden in applications, files, and databases,” said Bob Stanley, formerly CEO of IO Informatics and taking on the role of senior director, customer projects, with Melissa Informatics. “Informatics provides a way to turn normal working data into research quality data without expensive, hands-on electronic data capture. Our virtual data capture technique can save pharma firms billions of dollars by avoiding clinical trials and augmenting data with freely available clinical enrichment data.”
As part of Melissa’s global operations, Melissa Informatics is optimized to meet customers’ data processing, support, and security needs worldwide. Melissa Informatics leverages geo-located servers for fast, efficient data performance, and is certified compliant to SOC2, HIPAA, and HITECH regulations. To connect with Melissa Informatics or members of Melissa’s global intelligence team, visit www.Melissa.com or call 1-800-MELISSA.
About Melissa
Since 1985, Melissa has specialized in global intelligence solutions to help organizations unlock accurate data for a more compelling customer view. More than 10,000 clients worldwide in arenas such as retail, education, healthcare, insurance, finance, and government, rely on Melissa for full spectrum data quality and ID verification software, including data matching, validation, and enhancement services to gain critical insight and drive meaningful customer relationships. For more information or free product trials, visit www.Melissa.com or call 1-800-MELISSA (635-4772).
| Greg Brown Vice President, Marketing Melissa [email protected] (800) 635-4772 x1130 | Jackie Zerbst MPowered Public Relations [email protected] (714) 998-3448 |


Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook
Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns
Treasury Wine Estates Shares Jump as U.S. Overhaul Lifts FY2026 Outlook
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook
DeepSeek to Raise AI API Prices as Demand for New Models Surges
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins
Deutsche Bank Upgrades Persimmon to Buy After Strong First-Half Results
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+ 



